Dtsch Med Wochenschr 2010; 135(48): 2417-2419
DOI: 10.1055/s-0030-1247875
Aktuelle Diagnostik & Therapie | Review article
Hypertensiologie, Diabetologie
© Georg Thieme Verlag KG Stuttgart · New York

Neue Zielblutdruckwerte in der antihypertensiven Therapie diabetischer Patienten?

New targets for blood pressure lowering in diabetic patients?U. Kintscher1
  • 1Center for Cardiovascular Research (CCR), Institut für Pharmakologie, Charité – Universitätsmedizin Berlin
Further Information

Publication History

eingereicht: 13.9.2010

akzeptiert: 21.10.2010

Publication Date:
16 November 2010 (online)

Literatur

  • 1 The ACCORD Study Group . Effects of intensive blood-pressure control in type 2 diabetes mellitus.  N Engl J Med. 2010;  362 1575-1585
  • 2 Berthold H K, Gouni-Berthold I, Bestehorn K P, Bohm M, Krone W. Kardiovaskuläre Risikofaktoren bei Typ-2-Diabetikern in Deutschland – ein Versorgungsparadox.  Dtsch Ärztebl. 2007;  104 A861-867
  • 3 Cooper-DeHoff R M, Gong Y, Handberg E M. et al . Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.  J Amer Med Ass. 2010;  304 61-68
  • 4 Kannel W B, Wilson P W, Zhang T J. The epidemiology of impaired glucose tolerance and hypertension.  Am Heart J. 1991;  121 1268-1273
  • 5 Mancia G, De Backer G, Dominiczak A. et al . 2007 Guidelines for the management of arterial hypertension.  J Hypertens. 2007;  25 1105-1187
  • 6 Mancia G, Laurent S, Agabiti-Rosei E. et al . Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.  J Hypertens. 2009;  27 2121-2158
  • 7 Messerli F H, Mancia G, Conti C R. et al . Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?.  Ann Intern Med. 2006;  144 884-893
  • 8 Patel A, MacMahon S, Chalmers J. et al . Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.  Lancet. 2007;  370 829-840
  • 9 Patel A, MacMahon S, Chalmers J. et al . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.  N Engl J Med. 2008;  358 2560-2572
  • 10 Ryden L, Standl E. et al . Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary.  Eur Heart J. 2007;  28 88-136
  • 11 Schrier R W, Estacio R O, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.  Kidney Int. 2002;  61 1086-1097
  • 12 Stamler J, Vaccaro O, Neaton J D, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.  Diabetes Care. 1993;  16 434-444
  • 13 Tarnow L, Rossing P, Gall M A, Nielsen F S, Parving H H. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V.  Diabetes Care. 1994;  17 1247-1251
  • 14 UK Prospective Diabetes Study Group . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.  Brit Med J. 1998;  317 703-713

Prof. Dr. med. Ulrich Kintscher

Center for Cardiovascular Research (CCR)
Institut für Pharmakologie
Charité – Universitätsmedizin Berlin

Hessische Str. 3–4

10115 Berlin

Phone: 030/450525276

Fax: 030/450525901

Email: ulrich.kintscher@charite.de

    >